Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers. 

Pharmaceutical

Plus Therapeutics

Plus Therapeutics' headquarters in Austin, TX, United States

Marc Hedrick

Kara Quinlan Davis

Daniel Ortega

Russ H.

Russ Havranek

Andrew Sims

Richard J. Hawkins

An van Es-Johansson

Robert Lenk

Howard Clowes

Michael Vogelbaum

Manish Aghi

Nicholas Butowski

Russell Lonser

John McKew

Vladimir P. Torchilin

Andrew Brenner

Alireza Mohammadi

The Clinical Research Team at Plus Therapeutics is responsible for designing and overseeing clinical trials to evaluate the safety and efficacy of innovative radiotherapeutics for rare cancers. They collaborate with clinical advisors and research associates to ensure compliance with regulatory standards, manage patient recruitment, and analyze trial data to advance the company’s therapeutic pipeline. Their work is pivotal in bringing new treatment options to patients with challenging oncological conditions.

Clinical Research Team

The Finance and Corporate Strategy Team at Plus Therapeutics plays a critical role in managing the company's financial health and guiding its strategic direction. This team is responsible for financial planning, analysis, and reporting, as well as identifying growth opportunities through corporate strategy and new product planning. By ensuring fiscal responsibility and aligning financial resources with the company's mission to develop targeted radiotherapeutics, they support the overall goal of advancing innovative cancer treatments.

Finance and Corporate Strategy Team

The Drug Development Team at Plus Therapeutics focuses on advancing innovative radiotherapeutic solutions through rigorous research and clinical trials. Led by the Senior Director of Drug Development and Production, along with contributions from experienced scientific advisors and the VP of Clinical Operations, the team collaborates to design and execute strategies that ensure effective drug formulation, regulatory compliance, and successful patient enrollment in clinical studies. Their ultimate goal is to bring targeted cancer therapies from the lab to patients in need.

Drug Development Team

The Leadership Team at Plus Therapeutics is responsible for guiding the company’s strategic direction and operational execution, overseeing financial management, corporate strategy, and new product development. They collaborate closely to drive innovation in targeted radiotherapeutics, ensuring alignment with the mission to address rare and challenging cancers while fostering growth and maximizing shareholder value.

Leadership Team

Plus Therapeutics

Org chart

Board & advisors

Teams

Clinical Research Team

Finance and Corporate Strategy Team

Drug Development Team

Leadership Team

Offices

Plus Therapeutics

Org chart

Board & advisors

Teams

Clinical Research Team

Finance and Corporate Strategy Team

Drug Development Team

Leadership Team

Offices

Related companies